Galaxy Surfactants Limited (GALAXYSURF)
📢 Recent Corporate Announcements
Galaxy Surfactants Limited has announced its schedule for upcoming analyst and institutional investor interactions in Mumbai. Company officials will attend a Non-Deal Roadshow hosted by Nuvama IE on September 8, 2026 (9:00 am to 5:00 pm) and 1x1 / Group meetings on September 10, 2026 (9:00 am to 5:00 pm). The interactions will be held in person, and the company stated that no unpublished price sensitive information (UPSI) will be shared.
- Non-Deal Roadshow hosted by Nuvama IE scheduled on September 8, 2026 (9:00 am to 5:00 pm) in Mumbai.
- 1x1 and Group investor meetings scheduled on September 10, 2026 (9:00 am to 5:00 pm) in Mumbai.
- All meetings will be conducted in-person using only publicly available information.
- Intimation filed pursuant to Regulation 30(6) of SEBI LODR Regulations, 2015.
Galaxy Surfactants Limited has announced its participation in an upcoming investor conference organized by Elara Capital. The in-person meeting is scheduled for September 2, 2026, from 2:00 pm to 5:00 pm IST. The company confirmed that discussions will rely exclusively on publicly available information, with no unpublished price-sensitive information (UPSI) to be shared. This represents a routine procedural filing under Regulation 30 of SEBI LODR.
- Scheduled meeting date: September 2, 2026
- Meeting time window: 2:00 pm to 5:00 pm IST
- Organizer: Elara Capital Conference (In-person mode)
- No unpublished price sensitive information (UPSI) will be discussed
Galaxy Surfactants released its Q1 FY27 earnings call transcript, highlighting a record quarterly EBITDA of ₹252.5 crore, up 87% YoY from ₹135.1 crore in Q1 FY26. Consolidated volumes grew 5% YoY, led by an 11% volume growth in India and 6% growth in Rest of the World markets. EBITDA per metric ton rose sharply to ₹35,458 compared to ₹20,009 in the prior-year period. Management indicated that its Mexico EPC project remains on track for commercialization within the next 12 months.
- Quarterly EBITDA reached a record ₹252.5 crore compared to ₹135.1 crore in Q1 FY26
- EBITDA per metric ton improved to ₹35,458 from ~₹20,009 in Q1 FY26
- Consolidated volume grew 5% YoY, driven by 11% growth in India and 6% in Rest of the World
- AMET region volumes recovered 19% sequentially (QoQ) despite early geopolitical headwinds
- Mexico EPC project on track for commercialization over the next 12 months
Galaxy Surfactants Ltd. has signed a Partnership Growth Charter with global FMCG major Unilever, marking a new phase in their 45-year relationship. The charter serves as a strategic framework to accelerate new chemistries, next-generation surfactant technologies, and bio-based, lower-carbon alternatives. While the filing does not disclose specific contract values or volume commitments, Unilever represents a core customer in the home and personal care segment. Against Galaxy's TTM revenue of ₹5,752 Cr, this agreement reinforces long-term customer stickiness and collaborative R&D pipeline visibility.
- Signed a Partnership Growth Charter with Unilever, expanding their 45-year longstanding relationship
- Focuses on next-generation surfactant technologies, bio-based alternatives, and lower-carbon chemistries
- Integrates Galaxy's surfactant science with Unilever's formulation and consumer innovation capabilities
- Commercial deal value and volume commitments: not disclosed
Galaxy Surfactants reported its highest-ever quarterly EBITDA of ₹252.5 Cr for Q1 FY27, an 86.9% YoY increase. Revenue grew 38.5% YoY to ₹1,785.2 Cr, driven by a return to double-digit volume growth in India and sustained momentum in Specialty Care. Profitability metrics improved sharply, with EBITDA per Metric Tonne (MT) rising to ₹35,458 from ₹20,009 in the previous year. Despite geopolitical headwinds in the AMET region causing a low-single-digit volume decline, the company saw a strong sequential recovery in that market.
- Highest-ever quarterly EBITDA of ₹252.5 Cr, representing a 107.1% sequential increase from Q4 FY26.
- PAT more than doubled YoY to ₹165.9 Cr, compared to ₹79.5 Cr in Q1 FY26.
- EBITDA per Metric Tonne (MT) surged 77% YoY to ₹35,458, reflecting a significantly improved product mix.
- India region returned to double-digit volume growth, while Specialty Care sustained international momentum.
- Consolidated revenue of ₹1,785.2 Cr for the quarter represents approximately 34% of the total TTM revenue.
Galaxy Surfactants reported a robust Q1 FY27 with consolidated revenue growing 39.4% YoY to ₹1,781.9 Cr. Net profit surged 108.7% YoY to ₹165.9 Cr, driven by a significant expansion in EBITDA margins to 14.1% from 10.5% in the previous year. Volume growth was led by the India market (double-digit), while the AMET region saw a slight decline due to geopolitical issues. EBITDA per tonne reached a high of ₹35,458, reflecting better product mix and pricing discipline despite volatile raw material costs.
- Consolidated PAT grew 108.7% YoY to ₹165.9 Cr for the quarter ended June 30, 2026
- EBITDA per Metric Tonne (MT) improved significantly to ₹35,458/MT
- India volumes returned to double-digit growth after nearly two years of stagnation
- Specialty Care segment revenue reached ₹603.2 Cr, contributing 34% of total revenue
- Fatty Alcohol prices averaged $2,806/MT in Q1 FY27 compared to $2,751/MT in Q4 FY26
Galaxy Surfactants reported a robust start to FY27, with consolidated revenue growing 39.4% YoY to ₹1,781.90 Cr. Net profit surged 108.7% YoY to ₹165.92 Cr, a significant recovery from the ₹79.49 Cr reported in the same quarter last year. The company also secured a favorable legal outcome as the Ankleshwar District Court quashed eviction proceedings regarding land valued at ₹72.67 Cr. Performance was bolstered by a strong contribution from a subsidiary which added ₹430.07 Cr to the top line.
- Consolidated Revenue from operations rose 39.4% YoY to ₹1,781.90 Cr from ₹1,277.92 Cr.
- Consolidated Profit After Tax (PAT) increased 108.7% YoY to ₹165.92 Cr.
- Quarterly Basic EPS jumped to ₹46.80 from ₹22.42 in the year-ago period.
- Ankleshwar District Court quashed GIDC eviction proceedings for land with a carrying value of ₹72.67 Cr.
- One subsidiary alone contributed ₹430.07 Cr in revenue and ₹47.84 Cr in PAT for the quarter.
Galaxy Surfactants Limited concluded its 40th Annual General Meeting on August 12, 2026, with all five proposed resolutions passing with significant majorities. Shareholders formally approved a final dividend of ₹22 per equity share for the financial year 2025-26. The dividend resolution received near-unanimous support with 100% of the 2.97 crore votes polled in favor. Other approved items included the adoption of FY26 financial statements and the re-appointment of Director Mr. K. Natarajan.
- Final dividend of ₹22 per equity share approved for FY 2025-26
- Dividend resolution passed with 2,97,69,739 votes in favor (100.00%)
- Total of 47,084 shareholders were on record as of the August 5, 2026 record date
- Re-appointment of Director Mr. K. Natarajan approved with 99.93% majority
- Ratification of Cost Auditors' remuneration passed with 99.99% support
Galaxy Surfactants held its 40th AGM on August 12, 2026, where shareholders considered five key resolutions including the adoption of FY26 financial results. A final dividend of ₹22 per equity share was proposed for approval, representing a payout of approximately 29% against the FY26 EPS of ₹75.40. The meeting also addressed the re-appointment of Managing Director Mr. K. Natarajan and ratified cost auditor remuneration. Management discussed the company's performance, which saw TTM revenue reach ₹5,248 crore with an operating margin of 9.0%.
- Final dividend of ₹22 per equity share approved for the financial year 2025-26
- Re-appointment of Mr. K. Natarajan as Director who retired by rotation
- Remote e-voting was conducted between August 9 and August 11, 2026
- Auditor's Report for the year ended March 31, 2026, contained no qualifications or observations
- Company maintained a TTM revenue of ₹5,248 crore and a net worth of ₹1,578 crore
Galaxy Surfactants has approved the grant of 8,400 stock options to eligible employees under its Performance Stock Option Plan 2025 (PSOP 2025). These options are priced at the face value of Rs. 10 per share, representing a significant discount to the current market price. The vesting is structured for the long term, occurring only after the Annual General Meeting for the Financial Year 2028-29. Given the small quantity of shares, the dilution impact on existing shareholders is negligible.
- Grant of 8,400 stock options to eligible employees under the PSOP 2025 scheme.
- Exercise price set at Rs. 10 per share, equal to the face value of the equity shares.
- Vesting schedule is deferred until after the Annual General Meeting for FY 2028-29.
- Exercise period is 4 years from the date of vesting, after which unexercised options will lapse.
Galaxy Surfactants Limited has filed its quarterly compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. The filing, issued by Registrar & Transfer Agent MUFG Intime India Pvt. Ltd., confirms that share certificates received for dematerialization during the quarter ended June 30, 2026, were processed according to regulatory standards. This includes the mutilation and cancellation of certificates and updating the register of members. This is a standard administrative procedure for all listed entities and has no impact on the company's financial or operational standing.
- Compliance certificate issued for the quarter ended June 30, 2026.
- Registrar & Transfer Agent (RTA) confirmed as MUFG Intime India Pvt. Ltd.
- Verification that dematerialized securities are listed on the stock exchanges where earlier securities were listed.
- Confirmation of certificate mutilation and cancellation within prescribed timelines.
Galaxy Surfactants has fixed July 31, 2026, as the record date to determine shareholder eligibility for the final dividend of the financial year 2025-26. The dividend payout is contingent upon approval at the company's 40th Annual General Meeting (AGM), which is scheduled for August 12, 2026. This announcement follows the company's previous communication on May 14, 2026, regarding the AGM schedule. While the specific dividend amount per share is not disclosed in this filing, the company maintains a solid financial profile with a TTM PAT of Rs 267 Cr and an EPS of Rs 75.40.
- July 31, 2026, is the fixed record date for final dividend eligibility.
- The 40th Annual General Meeting is scheduled to be held on August 12, 2026.
- Initial intimation regarding the AGM schedule was provided on May 14, 2026.
- Dividend payment is subject to shareholder approval at the upcoming August 12 meeting.
Galaxy Surfactants has announced the closure of its trading window for all designated persons starting July 1, 2026. This action is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, ahead of the financial results for the quarter ending June 30, 2026. The window will remain closed until 48 hours after the results are officially declared. This is a standard regulatory procedure and does not reflect on the company's operational performance.
- Trading window closure begins on July 1, 2026
- Closure pertains to the financial results for the quarter ended June 30, 2026
- Window to reopen 48 hours after the declaration of quarterly results
- Restriction applies to all designated persons and their immediate relatives
Galaxy Surfactants Limited has scheduled a Non-Deal Roadshow in Chennai for June 25, 2026. The event will involve 1x1 and group meetings with institutional investors and analysts between 10:00 AM and 5:00 PM. The company stated that discussions will be limited to publicly available information, with no unpublished price sensitive information (UPSI) being shared. This is a routine regulatory disclosure under SEBI Listing Obligations and Disclosure Requirements.
- Non-Deal Roadshow scheduled for June 25, 2026, in Chennai.
- Meetings will be held in 1x1 and group formats from 10:00 AM to 5:00 PM.
- Discussions will focus strictly on publicly available information to comply with SEBI regulations.
- The event is part of the company's regular institutional investor engagement strategy.
Galaxy Surfactants Limited has scheduled an in-person participation in an Investor Conference organized by ICICI Securities. The event is set to take place on June 8, 2026, from 10:00 am to 5:00 pm. The company has explicitly stated that discussions will be restricted to publicly available information, ensuring no unpublished price sensitive information (UPSI) is disclosed. This disclosure is a standard regulatory requirement under SEBI (LODR) Regulations, 2015.
- Investor Conference scheduled for June 8, 2026, from 10:00 am to 5:00 pm.
- The event is organized by ICICI Securities and will be held in an in-person format.
- Compliance with Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
- Company confirms that no unpublished price sensitive information (UPSI) will be shared during the meet.
Financial Performance
Revenue Growth by Segment
Consolidated revenue from operations grew 11.3% YoY to INR 4,223.67 Cr in FY25 from INR 3,794.38 Cr. Performance Surfactants volume grew 5.0% to 1,67,423 MT, while Specialty Care volume remained nearly flat with 0.2% growth to 89,375 MT. Standalone revenue grew 9.3% to INR 3,001.27 Cr.
Geographic Revenue Split
Volume distribution for FY25: India contributed 44% (1,12,977 MT, down 1.9% YoY), AMET (Africa, Middle East, Turkey) contributed 27% (69,274 MT, down 1.0% YoY), and Rest of the World (ROW) contributed 29% (74,547 MT, up 17.6% YoY).
Profitability Margins
Consolidated PAT margin declined to 7.2% in FY25 from 7.9% in FY24. Standalone PAT margin was 5.8% compared to 7.3% in the previous year. The decline is attributed to lower fixed cost absorption and margin pressures across segments despite stable volumes.
EBITDA Margin
Consolidated EBITDA margin was 12.1% in FY25, a decrease from 13.1% in FY24. EBITDA per tonne decreased 0.8% to INR 19,868. Total consolidated EBITDA rose 2.5% to INR 510.04 Cr due to higher overall volumes despite the margin compression.
Capital Expenditure
The group is expected to incur capital expenditure of INR 150-175 Cr per annum over the medium term. This capex is planned to be funded entirely through internal accruals of over INR 300 Cr per annum.
Credit Rating & Borrowing
CRISIL AA-/Stable (Long Term) and CRISIL A1+ (Short Term) reaffirmed as of October 2025. Interest coverage ratio remained healthy at over 25 times in FY25, though it decreased from 37 times in FY24 due to higher finance charges of INR 19.25 Cr.
Operational Drivers
Raw Materials
Oleochemical-based fatty alcohols (primary source), petrochemical-based surfactants (competitor source). Raw material costs are a significant portion of the cost structure, though specific percentage splits per material are not disclosed.
Import Sources
Not explicitly disclosed, but the company operates a major subsidiary in Egypt (Galaxy Chemicals S.A.E.) to service the AMET region and sources globally for its Indian operations.
Capacity Expansion
Galaxy is the largest player of surfactants derived from oleochemical sources in India. Specific MTPA capacity figures are not provided, but the company is currently going slow on commercializing pipeline projects due to inflationary concerns.
Raw Material Costs
Raw material price volatility and shipment delays impacted margins in previous cycles (e.g., FY22 margin drop to 10.9%). Procurement is managed through a mix of sourcing efficiencies and passing on costs to customers where possible.
Manufacturing Efficiency
EBITDA per tonne is the primary efficiency metric, which stood at INR 19,868 in FY25. Fixed cost absorption was lower in FY24/FY25, impacting overall margins.
Logistics & Distribution
Distribution is global, with ROW volumes growing 17.6% in FY25. Logistics costs are sensitive to global freight rates and supply chain disruptions.
Strategic Growth
Expected Growth Rate
12-14%
Growth Strategy
Strategy involves aggressive marketing in Tier 2 and Tier 3 Indian cities to recoup volume losses in Tier 1, hunting for new customers in ROW markets (which grew 17.6% in FY25), and focusing on high-margin specialty care products. The company is also executing an EPC contract for a construction-type project to generate fee income.
Products & Services
Surfactants and specialty chemicals used as intermediates in the Home and Personal Care (HPC) industry, including ingredients for shampoos, detergents, and skin care products.
Brand Portfolio
Galaxy Surfactants (Corporate Brand). Specific consumer-facing brand names are not owned as the company is a B2B supplier.
New Products/Services
Focus on 'Specialty Care' segment products; however, new product revenue contribution percentages are not specifically disclosed.
Market Expansion
Expansion is focused on the ROW (Rest of World) market, specifically Latin America and APAC, which showed strong results in Q2 FY26.
Market Share & Ranking
Established leader in the HPC intermediates market in India; largest player of oleochemical-based surfactants in the country.
External Factors
Industry Trends
The HPC industry is shifting toward sustainable, oleochemical-based ingredients. Galaxy is positioned as a leader in this shift, moving away from petrochemical sources. The industry is currently seeing flat to 2% volume growth globally.
Competitive Landscape
Competitors include manufacturers of petrochemical-based surfactants. Galaxy competes on its 'green' oleochemical profile and large-scale manufacturing capacity.
Competitive Moat
Moat is built on 40+ years of technical expertise in surfactants, deep-rooted relationships with global FMCG majors, and a specialized manufacturing footprint that is difficult for competitors to replicate quickly.
Macro Economic Sensitivity
Highly sensitive to global inflation, which dampens consumer demand in the HPC sector and leads to lower volume growth (only 3.3% total volume growth in FY25).
Consumer Behavior
Shift toward premiumization and specialty personal care products in ROW markets is driving the 17.6% volume growth in that segment.
Geopolitical Risks
Geopolitical uncertainties in the AMET region and potential tariff wars are cited as factors that could either disrupt supply or create opportunities in international markets.
Regulatory & Governance
Industry Regulations
Operations are subject to SEBI (LODR) Regulations 2015 for disclosures and Ind AS 116 for lease accounting. Manufacturing must meet global standards for HPC intermediates.
Taxation Policy Impact
Effective tax rate for FY25 was approximately 19.8% (INR 75.54 Cr tax on INR 380.45 Cr PBT).
Risk Analysis
Key Uncertainties
Volatility in raw material prices (fatty alcohols) and global demand slowdown due to inflation (potential 5-10% impact on volume growth).
Geographic Concentration Risk
India and AMET account for 71% of total volumes (1,82,251 MT out of 2,56,798 MT), making the company vulnerable to regional economic downturns.
Third Party Dependencies
Dependency on global shipping lines for the ROW and AMET segments; disruptions can lead to high inventory carrying costs (65-75 days).
Technology Obsolescence Risk
Risk is mitigated by continuous focus on specialty chemicals and oleochemical surfactants, which are currently the preferred technology over petrochemicals.
Credit & Counterparty Risk
Receivables are 60-65 days; the company deals with established FMCG majors, which typically implies high credit quality of receivables.